BMY Dividend: Bristol-Myers Squibb Co Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	48,034	48,300	45,006	46,159	46,385	42,518
Revenue Growth (YoY)	1%	7%	-3%	0%	9%	63%
Cost of Revenue	12,898	11,949	10,602	10,074	9,601	11,133
Gross Profit	35,136	36,351	34,404	36,085	36,784	31,385
Selling, General & Admin	7,167	7,992	7,678	7,803	7,688	7,733
Research & Development	9,719	9,782	9,178	9,411	9,532	9,519
Operating Expenses	19,040	24,806	23,545	24,694	25,510	25,413
Other Non Operating Income (Expenses)	-61	-165	-106	-90	18	34
Pretax Income	8,033	-8,379	8,440	7,713	8,098	-6,871
Income Tax Expense	1,987	554	400	1,368	1,084	2,124
Net Income	6,039	-8,948	8,025	6,327	6,994	-9,015
Net Income Growth	-183%	-212%	27%	-10%	-178%	-362%
Shares Outstanding (Diluted)	2,039	2,027	2,078	2,146	2,245	2,258
Shares Change (YoY)	0%	-2%	-3%	-4%	-1%	32%
EPS (Diluted)	2.96	-4.41	3.86	2.95	3.12	-3.99
EPS Growth	-183%	-214%	31%	-5%	-178%	-299%
Free Cash Flow	15,302	13,942	12,651	11,948	15,234	13,299
Free Cash Flow Per Share	7.5	6.87	6.08	5.56	6.78	5.88
Gross Margin	73.14%	75.26%	76.44%	78.17%	79.3%	73.81%
Operating Margin	33.5%	23.9%	24.12%	24.67%	24.3%	14.04%
Profit Margin	12.57%	-18.52%	17.83%	13.7%	15.07%	-21.2%
Free Cash Flow Margin	31.85%	28.86%	28.1%	25.88%	32.84%	31.27%
EBITDA	20,280	20,417	19,906	20,986	21,297	15,660
EBITDA Margin	42.22%	42.27%	44.22%	45.46%	45.91%	36.83%
D&A For EBITDA	4,184	8,872	9,047	9,595	10,023	9,688
EBIT	16,096	11,545	10,859	11,391	11,274	5,972
EBIT Margin	33.5%	23.9%	24.12%	24.67%	24.3%	14.04%
Effective Tax Rate	24.73%	-6.61%	4.73%	17.73%	13.38%	-30.91%

Follow-Up Questions











